Perrigo Investors Urged to Seek Lead Role in Securities Case Tied to Infant-Formula Unit

Overview

• The case, French v. Perrigo Company plc (No. 25-cv-09596), was filed November 17, 2025 in the Southern District of New York against the company and certain current and former executives under the Exchange Act.
• The complaint alleges Perrigo misled investors about underinvestment, manufacturing deficiencies, and remediation costs at the Nestlé-acquired infant formula business, which the plaintiffs say inflated reported results.
• Plaintiffs tie stock drops to disclosures on February 27, 2024, May 7, 2024, and August 6, 2025, culminating in a roughly 25% decline after Perrigo’s November 5, 2025 strategic review announcement and guidance cut.
• Perrigo said on November 5 it was initiating a strategic review of its infant formula unit and reassessing a previously announced $240 million investment in the business.
• Multiple firms—including Robbins Geller, Schall, DJS, Portnoy, Levi & Korsinsky, Lowey Dannenberg, and Rosen—are soliciting investors, class periods vary across notices, and no class has been certified to date.